Teva Pharma Industries Ltd ADR (TEVA)

Teva Pharmaceutical Industries Limited is a global pharmaceutical company whose ordinary shares are represented on the NYSE through an ADR, classified here as a depositary receipt tied to common stock. The business develops, manufactures, markets, and distributes generic medicines and biopharmaceutical products across the United States, Europe, Israel, and other international markets. Its portfolio spans a wide range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, patches, ointments, and creams, along with sterile, hormone, high-potency, and cytotoxic products. Teva also has a presence in central nervous system, respiratory, and oncology therapies, and provides active pharmaceutical ingredients, contract manufacturing services, and out-licensing arrangements. Selected branded products include BENDEKA, TREANDA, COPAXONE, AJOVY, AUSTEDO, UZEDY, ProAir RespiClick, and QVAR RediHaler. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.